Live
- Naini for new vistas to captivate people
- Can Food Cravings Impact Your Mental Health?
- Skincare and Air Pollution: 5 Simple Tips to Protect Your Skin from Toxic Air
- Calin Georgescu leads tight Romanian presidential race, runoff pricture unclear
- Edu institutions warned over denial of hall-tickets
- Sobhita, Naga Chaitanya to have ‘over eight hour long wedding rituals’
- Naqvi calls for unity amid communal tension in Sambhal; slams Oppn
- India must move ahead on path of unity, Constitution: Rahul Gandhi on Sambhal violence
- Rashmika Mandanna Drops Major Hint About Her Wedding Plans with Vijay Deverakonda
- Double murder accused arrested
Gastrointestinal tumours associated with higher mortality
Researchers have determined that certain gastrointestinal tumours are more deadly than previously assumed.
Researchers have determined that certain gastrointestinal tumours are more deadly than previously assumed. Gastrointestinal stromal tumours (GISTs) may be malignant cancer or benign and are most commonly found in the stomach and small intestine and have significant variability in terms of size and malignant behaviour.
The finding, published online in the Journal of Gastrointestinal Surgery, showed that GISTs that are less than two cm cause 12.1 per cent mortality rate for five years. Also, up to 30 per cent of patients have GISTs less than two cm in size, or slightly more than half an inch, the researchers noted.
More than 79 per cent of patients have localised disease of GISTs, while for 11.4 per cent the disease can spread to other regions. Previously, researchers did not expect any disease to have spread.
"While GISTs are rare, we have found that certain groups of these tumours result in a much higher mortality than expected," said Jason Sicklick, assistant professor at University of California-San Diego in US. For the study, the team identified 378 patients with malignant GISTs of less than two cms between 2001 and 2011.
